Daily Step Count Linked to Improved Cognitive Function, Study Finds
Health •
Research suggests that increasing daily steps can lead to better attention, focus, and decision-making.
Health News
Daily Step Count Linked to Improved Brain Function, Study Finds
Health •
Walking 8,875 steps per day may enhance cognitive skills like attention and decision-making, according to new research.
Personalized Skin Cancer Vaccine Shows Promise in Halving Death Risk
Health •
A novel mRNA-based vaccine, Intisomeran, has demonstrated significant success in a phase three trial, reducing the risk of death or recurrence of melanoma by 42% when used alongside immunotherapy.
Personalized Skin Cancer Vaccine Shows Promising Results in Halving Risk of Death or Recurrence
Health •
A novel mRNA vaccine, Intismeran, has demonstrated a significant reduction in melanoma progression, marking a potential breakthrough in cancer treatment.
Frozen Shoulder Cases Spike After Weather Shift, Doctor Notes
Health •
A general practitioner observes an increase in frozen shoulder complaints, highlighting a simple home-based solution for the condition.
Frozen Shoulder Cases Spike After Weather Changes, GP Advises Home Treatment
Health •
Dr. Philippa Kaye notes a surge in patients experiencing frozen shoulder following shifts in weather and outlines simple home-based remedies.
Popular Sleep Aids Before Surgery May Reduce Post-Operative Pain and Opioid Use, Study Finds
Health •
Research presented at ANESTHESIOLOGY 2026 suggests that taking melatonin or Ambien prior to surgery could lead to less pain and anxiety during recovery.
New Genetic Test Could Halve Risk of Death for High-Risk Prostate Cancer Patients
Health •
A genomic test called Decipher analyzes tumor tissue to identify men most likely to benefit from aggressive hormone therapy, potentially reducing unnecessary side effects.
Personalised Cancer Vaccine Shows Promise in Cutting Melanoma Recurrence
Health •
A new mRNA-based vaccine, combined with immunotherapy, significantly reduced the risk of skin cancer returning in a large clinical trial.